Assenagon Asset Management S.A. Rigel Pharmaceuticals Inc Transaction History

Assenagon Asset Management S.A.

$47.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	SELL	$0.72 - $1.56 $560,478 - $1.21 Million	-778,443 Reduced 28.1%	1,991,398 $2.89 Million
Q3 2023 Nov 06, 2023	SELL	$1.07 - $1.39 $914,525 - $1.19 Million	-854,697 Reduced 23.58%	2,769,841 $2.99 Million
Q2 2023 Jul 25, 2023	BUY	$1.12 - $1.82 $2.6 Million - $4.22 Million	2,317,250 Added 177.26%	3,624,538 $4.68 Million
Q1 2023 Apr 18, 2023	BUY	$1.25 - $2.0 $603,037 - $964,860	482,430 Added 58.49%	1,307,288 $1.73 Million
Q4 2022 Jan 12, 2023	SELL	$0.67 - $11.9 $1.24 Million - $22.1 Million	-1,854,992 Reduced 69.22%	824,858 $1.24 Million
Q3 2022 Oct 27, 2022	BUY	$1.1 - $12.2 $1.12 Million - $12.4 Million	1,020,104 Added 61.46%	2,679,850 $3.16 Million
Q2 2022 Jul 27, 2022	BUY	$0.67 - $3.19 $607,446 - $2.89 Million	906,636 Added 120.39%	1,659,746 $1.88 Million
Q1 2022 Apr 25, 2022	BUY	$2.22 - $3.45 $1.67 Million - $2.6 Million	753,110 New	753,110 $2.25 Million
Q4 2021 Feb 01, 2022	SELL	$2.36 - $3.57 $31,921 - $48,287	-13,526 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$3.35 - $4.93 $1.59 Million - $2.34 Million	-475,627 Reduced 97.23%	13,526 $46,000
Q4 2020 Feb 01, 2021	SELL	$2.35 - $3.74 $162,164 - $258,082	-69,006 Reduced 12.36%	489,153 $1.71 Million
Q3 2020 Oct 07, 2020	BUY	$1.78 - $4.13 $595,819 - $1.38 Million	334,730 Added 149.81%	558,159 $1.34 Million
Q2 2020 Jul 21, 2020	BUY	$1.41 - $2.05 $292,529 - $425,309	207,468 Added 1299.84%	223,429 $409,000
Q1 2020 Apr 17, 2020	SELL	$1.27 - $3.0 $140,676 - $332,307	-110,769 Reduced 87.41%	15,961 $25,000
Q4 2019 Jan 17, 2020	SELL	$1.6 - $2.43 $789,232 - $1.2 Million	-493,270 Reduced 79.56%	126,730 $271,000
Q3 2019 Oct 16, 2019	SELL	$1.63 - $2.62 $1.48 Million - $2.37 Million	-905,784 Reduced 59.37%	620,000 $1.16 Million
Q2 2019 Aug 12, 2019	BUY	$2.02 - $2.61 $1.15 Million - $1.49 Million	569,984 Added 59.63%	1,525,784 $3.98 Million
Q1 2019 Apr 26, 2019	BUY	$2.0 - $2.65 $745,664 - $988,004	372,832 Added 63.95%	955,800 $2.46 Million
Q4 2018 Jan 23, 2019	BUY	$2.08 - $3.36 $1.21 Million - $1.96 Million	582,968 New	582,968 $1.34 Million

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.81B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account